Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (211-220 of 242) with videos related to

Pageof 25
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survivalL Qin, K D Chavin, Y Ding, et al.
Leukemia|October 8, 2010
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cellsL Liu, M Yang, R Kang, et al.
The New England Journal of Medicine|August 30, 1990
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transductionS A Rosenberg, P Aebersold, K Cornetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.
Cancer Research|May 15, 1989
Local distribution and concentration of intravenously injected 131I-9.2.27 monoclonal antibody in human malignant melanomaS Del Vecchio, J C Reynolds, J A Carrasquillo, et al.
Cancer Research|May 16, 2000
Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunityK M Giezeman-Smits, H Okada, C S Brissette-Storkus, et al.
Journal of the National Cancer Institute|April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.
European Journal of Immunology|June 1, 1996
Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumorsL Zitvogel, P D Robbins, W J Storkus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patientsB Fisher, A M Keenan, B S Garra, et al.
Annals of Surgery|September 1, 1986
Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injectionM T Lotze, J A Carrasquillo, J N Weinstein, et al.
Pageof 25

Showing results (211-220 of 242) with videos related to

Sort By:
Pageof 25
Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1996
Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survivalL Qin, K D Chavin, Y Ding, et al.
Leukemia|October 8, 2010
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cellsL Liu, M Yang, R Kang, et al.
The New England Journal of Medicine|August 30, 1990
Gene transfer into humans--immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transductionS A Rosenberg, P Aebersold, K Cornetta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Combination therapy with interleukin-2 and alpha-interferon for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.
Cancer Research|May 15, 1989
Local distribution and concentration of intravenously injected 131I-9.2.27 monoclonal antibody in human malignant melanomaS Del Vecchio, J C Reynolds, J A Carrasquillo, et al.
Cancer Research|May 16, 2000
Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunityK M Giezeman-Smits, H Okada, C S Brissette-Storkus, et al.
Journal of the National Cancer Institute|April 21, 1993
Prospective randomized trial of high-dose interleukin-2 alone or in conjunction with lymphokine-activated killer cells for the treatment of patients with advanced cancerS A Rosenberg, M T Lotze, J C Yang, et al.
European Journal of Immunology|June 1, 1996
Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumorsL Zitvogel, P D Robbins, W J Storkus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patientsB Fisher, A M Keenan, B S Garra, et al.
Annals of Surgery|September 1, 1986
Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injectionM T Lotze, J A Carrasquillo, J N Weinstein, et al.
Pageof 25